Showing results (431-440 of 504) with videos related to

Sort By:
Pageof 51
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Frontiers in Medicine|October 14, 2022
Quantitative proteomics of small numbers of closely-related cells: Selection of the optimal method for a clinical settingKyra van der Pan, Sara Kassem, Indu Khatri, et al.
Cancers|June 2, 2021
Tracking the Antibody Immunome in Sporadic Colorectal Cancer by Using Antigen Self-Assembled Protein ArraysMaría González-González, José María Sayagués, Luis Muñoz-Bellvís, et al.
The Journal of Allergy and Clinical Immunology|March 22, 2021
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator ConferenceJason Gotlib, Tracy I George, Melody C Carter, et al.
Wiener Klinische Wochenschrift|November 27, 2012
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectivesPeter Valent, Michel Arock, Patrizia Bonadonna, et al.
Science Translational Medicine|December 23, 2016
First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseasesAldo Borroto, Diana Reyes-Garau, M Angeles Jiménez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2024
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNMPeter Valent, Karin Hartmann, Gregor Hoermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple MyelomaMarta Lasa, Laura Notarfranchi, Cristina Agullo, et al.
Cancers|April 30, 2021
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma PatientsRobéria Mendonça de Pontes, Juan Flores-Montero, Luzalba Sanoja-Flores, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM ConsortiumPeter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
Pageof 51